Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2003
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220471 Extracellular proteins coded by nucleic acids, receptor or membrane-bound proteins, amino acid sequence lacking the signal peptide; use as drugs as thrombolytic agents, interferons, interleukins, erythropoietins
11/27/2003US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
11/27/2003US20030220256 Truncated 24kDa basic fibroblast growth factor
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030220229 Modulate an immunological response by T cells of Type I diabetics which can be used as an indicator; derived from a region of proinsulin that spans the junction between the B chain and C peptide; inhibiting the development/progression
11/27/2003US20030219910 Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit
11/27/2003US20030219900 Method and marker for simple transformation and selection of recombinant protists
11/27/2003US20030219897 A vector for transfecting a plant cell, obtained from a tomato mosaic virus, a tobacco masaic virus, producing an antisense RNA or a suppressor RNA, for inhibiting or reducing of gene expression
11/27/2003US20030219888 Binding enzyme, toxin with inorganic catalyst or fusion proteins which are contained in achromobacter cells, for using diagnositic, therapeutic, and drug screening
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219870 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
11/27/2003US20030219869 Expression of recombinant human proteins in Tetrahymena
11/27/2003US20030219865 Comprises nucleotide sequences coding proteins which are expressed at low temperatures; model system for studying cold adaptation
11/27/2003US20030219864 Novel variants of RANKL protein
11/27/2003US20030219861 Preparing libraries of chimeric immunoglobulins which demonstrate increased specificity and are comprised of framework regions (FR) and for use as diagnostic and therapeutic tools; genetic vaccines; gene therapy
11/27/2003US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
11/27/2003US20030219856 Comprises nucleotide sequences coding chimeric membrane proteins for diagnosing and treating cancer; antiproliferative/antitumor/antiinflammatory agents
11/27/2003US20030219855 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination
11/27/2003US20030219851 Preparing mucin-type glycopeptides using transglycosylation activity of N-acetylgalactosaminidase
11/27/2003US20030219806 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
11/27/2003US20030219783 Comprises translationally competent ribosome complex bound to solid surface for analyzing/monitoring conformational dynamics and translation rates/kinetics
11/27/2003US20030219758 Comprises nucleotide sequences for diagnosis, prevention and treatment of metastasis, autoimmune and nervous system disorders
11/27/2003US20030219752 Preparing immunoglobulin library; high throughput assay; immunoassays; immunotherapeutics and/or diagnostics; anticarcinogenic agents
11/27/2003US20030219745 Novel nucleic acids and polypeptides
11/27/2003US20030219741 Novel full-length cDNA
11/27/2003US20030219740 DNA sequences isolated from human colonic epithelial cells
11/27/2003US20030219723 Bioassys for identifying hepatitis C viricidal agents; drug screening
11/27/2003US20030219443 Mycobacterium tuberculosis superoxide dismutase
11/27/2003US20030219439 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003US20030219437 Administering antibodies used as antagonists to CD antigen ligands on the cells, for prophylaxis of cardiovascular, gastrointestinal or urogenital disorders
11/27/2003US20030219428 Deoxyribonuclease formed by genetic engineering, used for prophylaxis respiratory system disorders, lupus erythematosus and/or genetic disorders
11/27/2003US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives
11/27/2003US20030219419 Alteration of cell membrane for new functions
11/27/2003US20030219408 Methods of making pharmaceutical compositions with minicells
11/27/2003US20030219403 Compositions and methods of tolerizing a primate to an antigen
11/27/2003CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2486913A1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486483A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003CA2484719A1 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
11/27/2003CA2484655A1 Transgenic ungulates capable of human antibody production
11/27/2003CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2481783A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/26/2003EP1365243A1 Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit
11/26/2003EP1365032A1 Marker molecules associated with lung tumors
11/26/2003EP1365022A1 Adiponectin-associated protein
11/26/2003EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies
11/26/2003EP1364963A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof
11/26/2003EP1364032A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
11/26/2003EP1364030A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/26/2003EP1364029A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364021A2 Compositions and methods relating to colon specific genes and proteins
11/26/2003EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
11/26/2003EP1364018A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364011A2 Modified thrombopoietin with reduced immunogenicity
11/26/2003EP1364005A2 A method for evolving a cell having desired phenotype and envolved cells
11/26/2003EP1364002A2 Process for the preparation of neutrophil inhibitory factor
11/26/2003EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors
11/26/2003EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363935A2 Ter sites and ter binding proteins
11/26/2003EP0980865B1 Physiologically active substance pf1191 and process for producing the same
11/26/2003EP0759693B1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS
11/26/2003EP0705278B1 Apoptose inhibitor
11/26/2003EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses
11/26/2003EP0590058B1 HUMANIZED Heregulin ANTIBODy
11/26/2003CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
11/26/2003CN1458170A New human protein with cancer inhibiting function and its encoding sequence
11/26/2003CN1458169A New human protein with function of improving mouse NIH/3T3 cell transformation and its encoding sequence
11/26/2003CN1458166A Rondom polypeptide library constructing method
11/26/2003CN1458165A Poly peptide matter and its preparing method and use
11/26/2003CN1458160A Gene recombination tumour blood vessel death factor PFK and its derivative fusion protein
11/26/2003CN1128876C Transferrin receptor genes of moraxella
11/26/2003CN1128875C Method for preparing polypeptide variants
11/25/2003USRE38331 Cells with altered betaine catabolism and their use in producing metabolites or enzymes
11/25/2003US6653459 Isolated nucleic acid encoding a polypeptide of given sequence; use in producing glycoproteins with minimal and uniform sugar residues; low antigenicity; side-effect reduction of drugs
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653447 ULBP DNA and polypeptides
11/25/2003US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653105 For production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device
11/25/2003US6653103 For inhibiting export of nucleic acids from nucleus to cytoplasm of a cell
11/25/2003US6653101 Transforming a eukaryotic host by transfection with transcription units containing genes encoding a transactivator; promoters; use for increasing amount of protein expressed
11/25/2003US6653098 Transforming cell with an expression vector comprising an isolated polynucleotide; solubilizing the inclusion bodies; refolding and purifying; urea, dithiothreitol and cysteine; angiogenesis inhibitors; anticarcinogenic agents
11/25/2003US6653072 Improving expression of a protein encoded by DNA substrate by assembling oligonucleotides into recombinant nucleic acids and using it to transform cells; recursive sequence recombination
11/25/2003US6653068 Generation of specific binding partners binding to (poly)peptides encoded by genomic DNA fragments or ESTs
11/25/2003US6652863 Creating fusion compounds by linking to auto-antigenic sequences
1 ... 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 ... 1125